You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
An experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study ...
In health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and more ...
Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech news ...
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for ...
A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in a ...
The decision to move ahead with new products in the absence of FDA authorization could spur other big manufacturers to do the ...
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market ...
Katherine Clark, a top House Democrat, received more than $100,000 in campaign donations from people linked to UnitedHealth ...
Roivant said Tuesday an experimental drug for a type of pulmonary hypertension achieved the goals of a mid-stage study — ...
Rural health systems are seeking partnership to survive, fueling a debate over competition and the rising cost of medical ...
The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed sandals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results